Fundraising Fox
/Companies
Sign in

Nirvana Sciences

Research Triangle Park, US · Delaware corporation · 2 known investors

Find your way into Nirvana Sciences

Sign up to see every warm intro you have to Nirvana Sciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nirvana Sciences team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Nirvana Sciences develops dyes, probes, and contrast agents for life science applications, including organic dyes with narrow emission profiles and a library of over 700 chlorin and bacteriochlorin designs. Its products target life science research and imaging uses.

BiotechDeep TechHealthtechNew Materials

Founders & leadership

RT
Russell ThomasNamed on SEC filing

Board

RW
Richard WestBoard director
LC
Lisa CooperBoard director
WB
Wayne BrinsterBoard director

Investors · 2

NC IDEAlisted by NC IDEADurham

Reported raises · per SEC filings

Form D private placements

$1.7M disclosed across 2 rounds · 2018–2021

▶$867KraisedMay 2021 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard WestDirector
  • Lisa CooperDirector
  • Russell ThomasExecutive Officer, Director, Promoter
  • Wayne BrinsterDirector
Offering amount
$1M
Amount sold
$867K
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$785.9KraisedJul 2018 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard WestDirector
  • Wayne BrinsterDirector
  • Russell ThomasExecutive Officer, Director, Promoter
  • Lisa CooperDirector
Offering amount
$1.5M
Amount sold
$785.9K
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 7 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$1.6M
National Institutes of Health (NIH)National Institutes of HealthPhase I2021$400K
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$3M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2018$300K
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2016$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2015$225K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2014$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Nirvana Sciences do?
Nirvana Sciences develops dyes, probes, and contrast agents for life science applications, including organic dyes with narrow emission profiles and a library of over 700 chlorin and bacteriochlorin designs. Its products target life science research and imaging uses.
Who are Nirvana Sciences's investors?
Nirvana Sciences's investors include Charlotte Angel Fund, NC IDEA.
How much funding has Nirvana Sciences raised?
Nirvana Sciences has disclosed $1.7M raised across 2 rounds.
Where is Nirvana Sciences headquartered?
Nirvana Sciences is headquartered in Research Triangle Park, US.